ORYPKY
Live / Applied — Third extension granted (statement of use) (as of 24 Oct 2025)
What this means for you
Not registered yet, but its 27 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98286004
- Mark type
- Stylized text
- Filed
- 27 Nov 2023
- Published for opposition
- 02 Apr 2024
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis and Alzheimer's
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 24 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2025 — SOU EXTENSION 3 GRANTED
- 24 Oct 2025 — SOU EXTENSION 3 FILED
- 24 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Apr 2025 — SOU EXTENSION 2 GRANTED
- 21 Apr 2025 — SOU EXTENSION 2 FILED
- 21 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2024 — SOU EXTENSION 1 GRANTED
- 22 Oct 2024 — SOU EXTENSION 1 FILED